All In MedTech

Device Trial Radar · NCT06282614

Performance and Safety of MUCOGYNE® Ovule as a Moisturizer

MOVHYDA (MUCO245) - Performance and Safety of MUCOGYNE® Ovule as a Moisturizer

Last checked: Nov 20, 2026Latest source record: Apr 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

33

Actual

Start

Apr 11, 2024

Primary completion

Feb 14, 2025

Study completion Feb 14, 2025

Sponsor

Lead sponsor
BiocodexNot on our public-company list
Sponsor type
Industry
Collaborators
Voisin Consulting Life Science (VCLS)
First posted
Feb 28, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this post-Market Clinical Follow-up (PMCF) study is to confirm the efficacy and safety of MUCOGYNE® Ovule in the maintainance of natural moisture of the vulvovaginal mucosa and in the compensation for any natural secretions deficiencies, when used in accordance with its approved labeling, in the context of vulvovaginal dryness.

Conditions

  • Vaginal Dryness

Interventions

  • Mucogyne OvuleDevice

    At inclusion visit (V0), the Investigator will ask the subject to use MUCOGYNE® Ovule 2 times a week until symptoms improve during 5 weeks (D35± 3) preferably at bedtime

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of the efficacy of MUCOGYNE® Ovule intra vaginal applications on subjects' vaginal dryness irrespective of the cause over a 35-day period of useTime frame: Day 0 to Day 35 ± 3

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • JEAN Christian's medical office

    Nogent-sur-Marne, France

  • Dr Raïssa APERANO-MAS's medical office

    Rennes, France

  • Dr Ramez GHADRI's medical office

    Orléans, France, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.